Redefining the Frontier of RNA Biology
At Alida Biosciences, we develop cutting-edge tools for RNA modification-based discovery, diagnostics, therapeutics, and biotechnological applications.
Our mission is to empower the evaluation of RNA code beyond primary sequence. Built on deep expertise in protein engineering and enzymology, our innovative technologies position us as leaders in epitranscriptomic tools development.
Our products enable highly sensitive RNA modification detection and quantification through a simple workflow and integrated bioinformatics pipeline—empowering confident exploration of complex biological mechanisms from early research to clinical breakthroughs.
Leadership Team
Gudrun Strengel, PhD
CEO & Co-Founder
Byron Purse, PhD
Co-Founder
Andrew Price, PhD
Vice President, R&D
Zachary Miles, PhD
Senior Director of Protein Engineering
Eric Davis, PhD
Head of Software & Bioinformatics
Doug Whitney
Director of Business Development
Scientific Advisory Board
Richard Gregory, PhD
Professor, Harvard Medical School Principal Investigator, Boston Children’s Hospital
Peter Dedon, PhD
Professor and Lead Principal Investigator, Massachusetts Institute of Technology
Ralph Kleiner, PhD
Associate Professor and Principal Investigator, Princeton University
